These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. Lin N; Dunn IF; Glantz M; Allison DL; Jensen R; Johnson MD; Friedlander RM; Kesari S J Neurosurg; 2011 Oct; 115(4):730-6. PubMed ID: 21721878 [TBL] [Abstract][Full Text] [Related]
15. Intrathecal chemotherapy for patients with meningeal carcinomatosis. Yoshida S; Morii K Surg Neurol; 2005 Jan; 63(1):52-5; discussion 55. PubMed ID: 15639526 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Chamberlain MC; Glantz M; Groves MD; Wilson WH Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682 [TBL] [Abstract][Full Text] [Related]
17. Use of magnetic resonance imaging to detect neoplastic meningitis: limited use in leukemia and lymphoma but convincing results in solid tumors. Pauls S; Fischer AC; Brambs HJ; Fetscher S; Höche W; Bommer M Eur J Radiol; 2012 May; 81(5):974-8. PubMed ID: 21371841 [TBL] [Abstract][Full Text] [Related]